NCT03652792
- Conditions
- Bioequivalence of Two Azilsartan Formulations
- Locations
-
- Phase I Clinical Trial Centre, Chinese University of Hong Kong Hong Kong, Sha Tin New Territories
Clinical trial condition
Explore clinical trials studying Bioequivalence of Two Azilsartan Formulations. Study availability and eligibility vary by location and protocol.
NCT03652792